Antabio
Novel Antibiotics Against Drug-Resistant Bacteria
Toulouse, France · Founded 2009 · $40.5M raised
- Headquarters
- Toulouse
- Founded
- 2009
- Business Model
- B2B
- Website
- antabio.com
- Total Funding
- $40.5M
- Last Round
- $27.0M Series BDec 2023
- Rounds
- 3
About
Antabio is a privately-held clinical-stage biopharmaceutical company founded in 2009 and headquartered in Toulouse, France, focused on developing novel antibacterial treatments targeting drug-resistant pathogens designated as critical priorities by the WHO and CDC. The company's lead program, Meropenem-Pilabactam (MEM-PIL), is a next-generation β-lactam/β-lactamase inhibitor combination designed to treat multidrug-resistant infections in hospital wards and ICUs, with a particular focus on life-threatening hospital-acquired infections. Antabio maintains a diversified pipeline addressing Gram-negative pathogens through both internal discovery programs and a collaboration with the Global Antibiotic Research and Development Partnership (GARDP). The company is supported by investors including the AMR Action Fund, EIC Fund, BNP Paribas Développement, and Turenne/Relyens Santé.
Summary
Antabio is a Biotech company based in Toulouse, France, founded in 2009. It has raised $40.5M in total across 3 rounds, most recently a $27.0M Series B round in Dec 2023. Investors include AMR Action Fund, IXO Private Equity and European Innovation Council Fund.
Tech & App Stack
4 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding History
Sign up to view the funding chart
Create a free account with 25 free credits every month, no card needed, to unlock funding history, valuations, and tech stacks.
Dec 2023
Sign up to see all 3 rounds
Seed through Series B — per-round amounts, valuations, and who invested in each round.
Investors
Similar Companies
China's leading blood products manufacturer
One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...
Global contract development and manufacturing organization (CDMO) focused exclusively on sterile ...
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/antabio"><img src="https://indexed.vc/api/badge/company/antabio" alt="Antabio on Indexed.vc" width="260" height="76" /></a>